ATE256753T1 - Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten - Google Patents

Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten

Info

Publication number
ATE256753T1
ATE256753T1 AT00945124T AT00945124T ATE256753T1 AT E256753 T1 ATE256753 T1 AT E256753T1 AT 00945124 T AT00945124 T AT 00945124T AT 00945124 T AT00945124 T AT 00945124T AT E256753 T1 ATE256753 T1 AT E256753T1
Authority
AT
Austria
Prior art keywords
sequence
base pair
primers
sequences
respect
Prior art date
Application number
AT00945124T
Other languages
English (en)
Inventor
Kent D Taylor
Maren Scheuner
Jerome Rotter
Huiying Yang
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Application granted granted Critical
Publication of ATE256753T1 publication Critical patent/ATE256753T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00945124T 1999-07-02 2000-06-30 Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten ATE256753T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/347,114 US6297014B1 (en) 1999-07-02 1999-07-02 Genetic test to determine non-responsiveness to statin drug treatment
PCT/US2000/018308 WO2001002606A2 (en) 1999-07-02 2000-06-30 Genetic test to determine non-responsiveness to statin drug treatment

Publications (1)

Publication Number Publication Date
ATE256753T1 true ATE256753T1 (de) 2004-01-15

Family

ID=23362384

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03028652T ATE513922T1 (de) 1999-07-02 2000-06-30 Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten
AT00945124T ATE256753T1 (de) 1999-07-02 2000-06-30 Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03028652T ATE513922T1 (de) 1999-07-02 2000-06-30 Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten

Country Status (9)

Country Link
US (2) US6297014B1 (de)
EP (2) EP1408121B1 (de)
AT (2) ATE513922T1 (de)
AU (1) AU5911100A (de)
DE (1) DE60007352T2 (de)
DK (1) DK1228241T3 (de)
ES (1) ES2211568T3 (de)
PT (1) PT1228241E (de)
WO (1) WO2001002606A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083862A2 (en) * 2001-04-13 2002-10-24 Johns Hopkins University School Of Medicine Methods and compositions for identifying disease genes using nonsense-mediated decay inhibition
US20020164598A1 (en) * 2001-05-03 2002-11-07 Ihc Health Services, Inc. Method for evaluating and applying an individual's genetic characteristics to determine response to cardiovascular medication therapy
US20030215819A1 (en) * 2001-06-29 2003-11-20 Frudakis Tony N. Compositions and methods for inferring a response to statin
US6723527B2 (en) * 2001-10-26 2004-04-20 Board Of Regents, The University Of Texas System Methods for determining toxicity reversing agents
AU2003276727A1 (en) * 2002-06-14 2003-12-31 Cedars-Sinai Medical Center Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
US8178294B2 (en) * 2002-06-14 2012-05-15 Cedars-Sinai Medical Center Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
US20040110241A1 (en) * 2002-12-06 2004-06-10 Segal Mark S. Materials and methods for monitoring vascular endothelial function
EP1592706A2 (de) * 2003-02-03 2005-11-09 Bayer HealthCare AG Genetischepolymorphismen als diagnostika, mit denen sich nebenreaktionen aufarzneimittel und arzneimittelwirksamkeit vorhersagenlassen
US8401801B2 (en) 2003-02-20 2013-03-19 Mayo Foundation For Medical Education And Research Methods for selecting medications
US8688385B2 (en) * 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
EP1704253A1 (de) * 2004-01-15 2006-09-27 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Zur erkennung von thrombophilie entwickeltes verfahren (mert)
DE602005013947D1 (de) * 2004-04-16 2009-05-28 Idexx Lab Inc Antikörper gegen hundepankreaslipase
CA2566257A1 (en) * 2004-05-07 2005-11-24 Applera Corporation Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
US8589175B2 (en) * 2005-11-29 2013-11-19 Children's Hospital Medical Center Optimization and individualization of medication selection and dosing
US20100130600A1 (en) * 2007-03-30 2010-05-27 Cedars-Sinai Medical Center Lipoprotein lipase and its effect on statin treatments
WO2009052179A2 (en) * 2007-10-15 2009-04-23 Idexx Laboratories, Inc. Feline pancreatic lipase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
CA2013317A1 (en) 1989-04-17 1990-10-17 Fred T. Oakes Diagnostic kit, primer composition and their use for replication or detection of nucleic acids

Also Published As

Publication number Publication date
EP1408121A3 (de) 2007-06-06
US20020106657A1 (en) 2002-08-08
EP1408121B1 (de) 2011-06-22
AU5911100A (en) 2001-01-22
US6297014B1 (en) 2001-10-02
WO2001002606A2 (en) 2001-01-11
EP1228241A2 (de) 2002-08-07
ES2211568T3 (es) 2004-07-16
EP1408121A2 (de) 2004-04-14
DE60007352D1 (de) 2004-01-29
WO2001002606A3 (en) 2002-06-13
DE60007352T2 (de) 2004-09-02
PT1228241E (pt) 2004-05-31
DK1228241T3 (da) 2004-04-19
EP1228241B1 (de) 2003-12-17
ATE513922T1 (de) 2011-07-15

Similar Documents

Publication Publication Date Title
ATE513922T1 (de) Genetischer test zur bestimmung der nicht- wirksamkeit einer behandlung mit statinmedikamenten
Bellone et al. Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus)
Nishisho et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
Gécz et al. FMR2 expression in families with FRAXE mental retardation
WO2001057274A8 (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
ATE360808T1 (de) Unabhängiges gerät zur extraktion, amplifikation und nachweis von nukleinsäuren
ATE251222T1 (de) Verfahren zur bestimung von ki-ras mutationen und dieses leistender testsatz
ATE121794T1 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
Ahn et al. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis
Steichen-Gersdorf et al. Deletion mapping on chromosome 17p in medulloblastoma
CA2382848A1 (en) Diagnostics and therapeutics for osteoporosis
ES2252159T3 (es) Polimorfismos en el gen humano del transportador de anion organico c (oatp-c).
DE69705936D1 (de) Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose
Shi et al. Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-γ-independent mechanisms
DE60136746D1 (de) Oligonucleotide zur markierung von oligonukleotidsonden und proteine
DE69425386D1 (de) Nukleotidsonden
NZ518458A (en) Isolate DNA polymerase lambda and uses thereof
Johnson et al. A 1.5-Mb contig within the cat eye syndrome critical region at human chromosome 22q11. 2
Proudnikov et al. Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history
Brand et al. Identification of two polymorphisms in the early growth response protein-1 gene: possible association with lipid variables
FR2791357B1 (fr) Diagnostic de la maladie de whipple
MXPA97000542A (es) Sondas de adn especificas para identificacion delas especies taenia solium y taenia saginata.
WO2001018240A3 (en) Diagnostic and therapeutic methods in autoimmune disease
Fujiwara et al. Prevention of cross-contamination during sampling procedure in molecular detection for cancer micrometastasis
Ali et al. Research Article Study of Cysteine-Rich Protein 61 Genetic Polymorphism in Predisposition to Fracture Nonunion: A Case Control

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1228241

Country of ref document: EP

REN Ceased due to non-payment of the annual fee